Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies
Co-amorphous drug delivery systems (CAMS) are characterized by the combination of two or more (initially crystalline) low molecular weight components that form a homogeneous single-phase amorphous system. Over the past decades, CAMS have been widely investigated as a promising approach to address th...
Saved in:
Main Authors: | Jingwen Liu (Author), Holger Grohganz (Author), Korbinian Löbmann (Author), Thomas Rades (Author), Nele-Johanna Hempel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations
by: Jaya Mishra, et al.
Published: (2018) -
Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline
by: Katrine Tarp Jensen, et al.
Published: (2014) -
Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
by: Marika Ruponen, et al.
Published: (2021) -
Destabilization of Indomethacin-Paracetamol Co-Amorphous Systems by Mechanical Stress
by: Rong Di, et al.
Published: (2023) -
Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug
by: Li Ming Lim, et al.
Published: (2022)